🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to determine if the endocannabinoid (...
Status
Completed
Location
Novant Health Forsyth Medical Center
Start Date
2019-01-25
Trial ID
NCT03752021
Treatments Being Tested
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
Background: Neurofibromatosis Type 1 (NF1) is a genetic disorder in which ...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2008-02-25
Trial ID
NCT00924196
An international, multi-center, prospective, blinded, randomized, controlle...
Status
Completed
Location
Piedmont Hospital
Start Date
2013-10
Trial ID
NCT01972139
The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Status
Completed
Location
UCLA Santa Monica Hematology / Oncology SC
Start Date
2016-10-14
Trial ID
NCT02890069
Treatments Being Tested
This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study d...
Status
Completed
Location
Honor Health (GIST, mastocytosis, other solid tumors)
Start Date
2015-11
Trial ID
NCT02571036
This is a non-randomized, dose-escalation first-in-human study to evaluate ...
Status
Completed
Location
Frontage Clinical Services, Inc.
Start Date
2022-08-22
Trial ID
NCT05523570
The objective of this study is the collection and testing of clinical sampl...
Status
Completed
Location
Etablissement Français du Sang (EFS) Hauts-de-France - Normandie
Start Date
2019-12-04
Trial ID
NCT04971343
Treatments Being Tested
This is a Phase I clinical trial evaluating abemaciclib (LY2835219), an inh...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2016-02
Trial ID
NCT02644460
Treatments Being Tested
First-in-human, Phase 1b/2 safety study of the antibody-drug conjugate (ADC...
Status
Completed
Location
University of Oklahoma
Start Date
2019-07-30
Trial ID
NCT06517485
Treatments Being Tested